Review: Genetics of systemic lupus erythematosus

Abstract

Get full access to this article

View all access options for this article.

References

Arnetti FC , Reveille JD Genetics of systemic lupus erythematosus. Rheum Dis Clin N Am 1992; 18: 865-892.

Arnett FC The genetic basis of lupus erythematosus. In: Wallace DJ , Hahn BH (eds) Dubois Lupus Erythematosus 4th edn. Philadelphia. Lea & Febiger, 1992.

Block SR et al. Studies of twins with systemic lupus erythematosus. A review of the literature and presentation of 12 additional sets. Am J Med 1975; 59: 533-552.

Kaplan D. The onset of disease in twins and siblings with systemic lupus erythematosus . J Rheumatol 1984; 11: 648-652.

Deapen D. et al. A revised estimate of twin concordance in systemic lupus erythematosus . Arthritis Rheum 1992; 35: 311-318.

Jarvinen P. et al. Systemic lupus erythematosus and related systemic diseases in a nationwide twin cohort: an increased prevalence of disease in MZ twins and concordance of disease features. J Intern Med 1992; 231: 67-72.

Buckman KJ et al. Familial systemic lupus erythematosus. Arch Intern Med 1978; 138: 1674-1676.

Lawrence JS , Martins CL , Drake GL A family survey of lupus erythematosus. 1. Heritability. J Rheumatol 1987; 14: 913-921.

Hochberg M. The application of genetic epidemiology to systemic lupus erythematosus. J Rheumatol 1987; 14: 867-869.

10.

Slor H. et al. The genetics of autoimmunity: the familial tendency of systemic lupus erythematosus. Isr J Med Sci 1989; 25: 678-682.

11.

Aggarwal A. et al. Occurrence of systemic autoimmune disorders and autoantibodies in household contacts of patients with systemic lupus erythematosus . Indian J Med Res 1991; 94: 96-98.

12.

Chantler S. et al. Incidence of nuclear antibodies in patients and in related and unrelated groups from a community with a 'micro-epidemic' of systemic lupus erythematosus. Clin Immunol Immunopath 1973; 2: 9-15.

13.

Isenberg DA et al. Detection of cross-reactive anti-DNA antibody idiotypes in the serum of systemic lupus erythematosus patients and of their relatives. Arthritis Rheum 1985; 28: 99-1007.

14.

Halpern R. et al. Familial systemic lupus erythematosus. Presence of a cross-reactive idiotype in healthy family members. J Clin Invest 1985; 76: 731-736.

15.

Silvestris F. et al. Family distribution of anti-F(ab')2 antibodies in relatives of patients with systemic lupus erythematosus. Clin Exp Immunol 1985; 60: 329-338.

16.

Spencer-Green G. et al. Familial alterations of immunoregulation in systemic lupus erythematosus. J Rheumatol 1985; 12: 498-503.

17.

Dudeney C. et al A study of anti-poly (ADP-ribose) antibodies and an anti-DNA antibody idiotype and other immunological abnormalities in lupus family members . Ann Rheum Dis 1986; 45: 502-507.

18.

Segal R. et al. Analysis of antigen specific T cell helper function in first degree relatives of patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 1986; 66: 52-60.

19.

Schattner A. et al. Supressor cell function and anti-DNA antibody idiotypes in the serum of SLE patients and their first-degee relatives . Clin Immunol Immunopathol 1986; 41: 417-426.

20.

Shoenfeld Y. et al. Detection of antibodies to total histones and their subfractions in systemic lupus erythematosus patients and their asymptomatic relatives. Arthritis Rheum 1987 ; 30: 169-175.

21.

Mackworth-Young C. et al. High incidence of anticardiolipin antibodies in relatives of patients with systemic lupus erythematosus. J Rheumatol 1987; 14: 723-726.

22.

Dang H. et al. Expression of an interspecies idiotype in sera of SLE patients and their first-degree relatives. Clin Exp Immunol 1988; 71: 445-450.

23.

LePage SH et al Relationship between tymphocytotoxic antibodies, anti-DNA antibodies and a common anti-DNA antibody idiotype PR4 in patients with systemic lupus erythematosus, their relatives and spouses. Clin Exp Immunol 1989; 77: 314-318.

24.

Silvestris F. et al. Studies of anti-F(ab')2 antibodies and VH region distribution among SLE kindreds. J Autoimmun 1989; 2: 395-401.

25.

Silvestris F. et al. Distribution of anti-F(ab')2 antibodies and the 16/6 idiotype in systemic lupus erythematosus (SLE) probands and kindreds . J Clin Immunol 1989; 9: 462-468.

26.

Arnett FC et al. Genetic studies of Ro(SS-A) and La(SS-B) autoantibodies in families with systemic lupus erythematosus and primary Sjögren's syndrome. Arthritis Rheum 1989; 32: 413-419.

27.

Mendlovic S. et al. Anti-DNA idiotype and anti-idiiotype-specific T cell responses in patients with systemic lupus erythematosus and their first-degree relatives. Clin Exp Immunol 1990; 82: 504-508.

28.

Vasan RS et al. Lymphocytotoxic antibodies in patients with systemic lupus erythematosus and their household contacts. Indian J Med Res 1990; 92: 447-450.

29.

Sato EI et al. Systemic lupus erythematosus: a family study of 25 probands . Clin Exp Rheumatol 1991; 9: 455-461.

30.

Strom BL et al. Shingles, allergies, family medical history, oral contraceptives and other potential risk factors for systemic lupus erythematosus. Am J Epidemiol 1994; 140: 632-642.

31.

Haug BL , Lee JS , Sibley JT Altered poly(ADP-ribose) metabolism in family members of patients with systemic lupus erythematosus. J Rheumatol 1994; 21: 851-856.

32.

A. Scherak 0, Smolen JS, Mayr WR. HLA-DRw3 and systemic lupus erythematosus. Arthritis Rheum 1980; 23: 954-957.

33.

Winchester RJ Genetic aspects. In: Schur PH (ed.). Clinical Management of Systemic Lupus Erythematosus . Grune & Stratton: New York , 1983, pp 17-27.

34.

Whittingham S. et al. HLA and Gm genes in systemic lupus erythematosus. Tissue Antigens 1983; 21: 50-57.

35.

Whittingham S. , Propert DN , Mackay IR A strong association between the antinuclear antibody anti-La (SS-B) and the kappa chain allotype km(1). Immunogenetics 1984; 19: 295-299.

36.

Dunckley H. , Gatenby PA , Serjeantson SW DNA typing of HLA-DR antigens in systemic lupus erythematosus. Immunogenetics 1986; 24: 158-162.

37.

Dunckley H. et al. Deficiency of C4A is a genetic determinant of systemic lupus erythematosus in three ethnic groups. J Immunogenet 1987: 14: 209-218.

38.

Christiansen FT et al. Major histocompatibility complex (MHC) complement deficiency, ancestral haplotypes and systemic lupus erythematosus. C4 deficiency explains some but not all of the influence of the MHC. J Rheumatol 1991; 18: 1350-1358.

39.

Fernandes Srm et al. HLA antigens and susceptibility to systemic lupus erythematosus in Brazilian patients. Lupus 1995; 4: 43S.

40.

Benovolenskaia LI , Iakovleva DB , Folomeeva OM The importance of HLA antigens for the prognosis of the course and effect of treatment in systemic lupus erythematosus. Vutr. Boles 1988; 27: 48-52.

41.

Bell DA et al. HLA antigens in systemic lupus erythematosus: relationship to disease severity, age at onset and sex. J Rheumatol 1984; 11: 475-479.

42.

Goldstein R. , Smith CD , Sengar Dps. MHC class II studies of primary antiphospholipid antibody (aPLA) syndrome and of serum antiphospholipid antibodies in systemic lupus erythematosus (SLE). Arthritis Rheum 1990; 33: S125 (abstract).

43.

Goldstein R. , Sengar Dps. Comparative studies of HLA associations and C4A gene deletion in French Canadian and non-French Canadian Caucasians with SLE. Presented at the 15th Annual Meeting of the American Society of Histocompatibility and Immunogenetics, 12-21 September 1989, Toronto .

44.

Goldstein R. , Sengar DP Comparative studies of the major histocompatibility complex in French Canadian and non-French Canadian Caucasians with systemic lupus erythematosus. Arthritis Rheum 1993; 36: 1121-1127.

45.

Stenszky V. et al. Heterogeneity of systemic lupus erythematosus elucidated by cluster analysis. The influence of HLA. J Immunogen 1986; 13: 327-340.

46.

Gladman DD et al. Increased frequency of HLA-DRw2 in SLE. Lancet 1972; 2: 902-905.

47.

Hawkins BR et al. Strong association between the major histocompatibility complex and systemic lupus erythematosus in southern Chinese. J Rheumatol 1987; 14: 1128-1131.

48.

Doherty DG et al. Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus in southern Chinese. Arthritis Rheum 1992; 35: 641-646.

49.

Joung-Liang L. , Jen-Pey Su P. , Wen-Yin T. Complement C4 allotyping in patients with systemic lupus erythematosus in Chinese. J Rheum (ROC) 1987; 4: 23-29.

50.

Dostal C. et al. HLA antigens in SLE. Ann Rheum Dis 1977; 36: 83-85.

51.

Cowland JB et al. DNA polymorphism of HLA class II genes in systemic lupus erythematosus . Tissue Antigens 1994; 43: 34-37.

52.

Fugger L. et al. NcoI restriction fragment length polymorphism (RFLP) of the tumor necrosis factor (TNF alpha) region in four autoimmune diseases. Tissue Antigens 1989; 34: 17-22.

53.

Green JR , Montasser M. , Woodrow JC The association of HLA-linked genes with systemic lupus erythematosus. Ann Hum Genet 1986; 50: 93-96.

54.

Batchelor JR et al. Family study of the major histocompatibility complex in HLA DR3 negative patients with systemic lupus erythematosus. Clin Exp Immunol 1987; 70: 364-371.

55.

So AK et al. DNA polymorphism of major histocompatibility complex class II and class III genes in systemic lupus erythematosus. Tissue Antigens 1990; 35: 144-147.

56.

Briggs DC et al. Influence of C4 null alleles on C4 activation in systemic lupus erythematosus. Ann Rheum Dis 1991; 50: 251-254.

57.

Galeazzi M. et al. HLA-DP genotyping in patients with systemic lupus erythematosus: correlations with autoantibody subsets. J Rheumatol 1992; 19: 42-46.

58.

Davies EJ et al. HLA-DQ, DR and complement C4 variants in systemic lupus erythematosus . Br J Rheumatol 1993; 32: 870-875.

59.

Davies EJ et al. HLA-DP does not contribute towards susceptibility to systemic lupus erythematosus. Ann Rheum Dis 1994; 53: 188-190.

60.

Davies EJ et al. Polymorphisms of the TAP2 transporter gene in systemic lupus erythematosus. Ann Rheum Dis 1994; 53: 61-63.

61.

Wilson AG et al. A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha. Eur J Immunol 1994; 24: 191-195.

62.

Partanen J. , Koskimies S. , Johansson E. C4 null phenotypes among lupus erythematosus patients are predominantly the result of deletions covering C4 and closely linked 21-hydroxylase A genes. J Med Genet 1988; 25: 387-391.

63.

Ruuska P. et al. Differences in HLA antigens between patients with mixed connective tissue disease and systemic lupus erythematosus. Ann Rheum Dis 1992; 51: 52-55.

64.

Stoppa-Lyonnet D. et al. Familial studies of systemic lupus erythematosus. HLA markers and complotypes. Pathol Biol 1986; 34: 773-777.

65.

Gougerot A. et al. HLA markers and complotypes: risk factors in systemic lupus erythematosus? Ann Dermatol Venereol 1987; 114: 329-334.

66.

Clemenceau S. et al. C4 null alleles in childhood onset systemic lupus erythematosus. Is there any relationship with renal disease ? Pediatr Nephrol 1990; 4: 207-212.

67.

Fan Q. et al. Complement component C4 deficiencies and gene alterations in patients with systemic lupus erythematosus. Eur J Immunogen 1993; 20: 11-21.

68.

Monplaisir N. et al. Study of HLA antigens in systemic lupus erythematosus in the French West Indies. Tissue Antigens 1988; 31: 238-242.

69.

Hartung K. et al. Association of class I, II and III MHC gene products with systemic lupus erythematosus. Results of a Central European multicenter study. Rheumatol Int 1989; 9: 13-18.

70.

Hartung K. et al. Major histocompatibility complex haplotypes and complement C4 alleles in systemic lupus erythematosus. Results of a multicenter study. J Clin Invest 1992; 90: 1346-1351.

71.

Bettinotti MP et al. Polymorphism of the tumor necrosis factor beta gene in systemic lupus erythematosus: TNFB-MHC haplotypes. Immunogenetics 1993; 37: 449-454.

72.

Yao Z. et al. No direct correlation between HLA-DPB 1 and antibodies against recombinant Ro(SS-A)/La (SS-B) proteins in systemic lupus erythematosus. Rheumatol Int 1993; 13: 155-158.

73.

Yao Z. et al. DNA typing for HLA-DPB 1-alleles in German patients with systemic lupus lupus erythematosus using the polymerase chain reaction and DIG-ddUTP-labelled oligonucleotide probes. Members of SLE Study Group. Eur J Immunogen 1993; 20: 259-266.

74.

Yao Z. et al. Polymorphism of the DQA 1 promoter region (QAP) and DRB 1, QAP, DQA1, DQB 1 haplotypes in systemic lupus erythematosus. SLE Study Group members . Immunogenetics 1993; 38: 421-449.

75.

Reveille JA et al. HLA class II alleles and C4 null genes in Greeks with systemic lupus erythematosus. Tissues Antigens 1995 (in press).

76.

Stenszky V. et al. Interplay if immunoglobulin G heavy chain markers (Gm) and HLA in predisposing to systemic lupus nephritis. J Immunogenet 1986; 13: 11-17.

77.

Mehra NK et al. Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus in northern India. Lupus 1993; 2: 313-314.

78.

Savi M. et al. HLA-DR antigens and anticardiolipin antibodies in Northern Italian systemic lupus erythematosus patients. Arthritis Rheum 1988; 31: 1568-1570.

79.

Lulli P. et al. HLA antigens in Italian patients with systemic lupus erythematosus: evidence for the association of DQw2 with the autoantibody response to extractable nuclear antigens. Clin Exp Rheumatol 1991; 9: 475-479.

80.

Galeazzi M. et al. HLA-DP genotyping in patients with systemic lupus erythematosus: correlations with autoantibody subsets. J Rheumatol 1992; 19: 42-46.

81.

Kameda S. et al. HLA antigens of patients with systemic lupus erythematosus. Tissue Antigens 1981; 20: 221-222.

82.

Hashimoto H. et al. HLA antigens associated with systemic lupus erythematosus in Japan. J Rheumatol 1985; 12: 919-923.

83.

Nishikai M. , Sekiguchi S. Relationship of autoantibody expression and HLA phenotype in Japanese patients with connective tissue diseases. Arthritis Rheum 1985; 28: 579-581.

84.

Hirose S. et al. Association of HLA-DR2/DR4 heterozygosity with systemic lupus erythematosus in Japanese patients. J Rheumatol 1988; 15: 1489-1492.

85.

Yamada H. et al. Lack of gene deletion for complement C4A deficiency in Japanese patients with systemic lupus erythematosus. J Rheumatol 1990; 17: 1054-1057.

86.

Dong RP et al. Difference in HLA-linked genetic background between mixed connective tissue disease and systemic lupus erythematosus. Tissue Antigens 1993; 41: 20-25.

87.

Hashimoto H. et al. HLA antigens in Japanese patients with systemic lupus erythematosus. Scand J Rheumatol 1994; 23: 191-196.

88.

Nishimura Y. HLA-linked susceptibility to intractable vasculitis syndrome. Nippon Rinsho 1994; 52: 2000-2005.

89.

Hong GH et al. Association of complement C4 and HLA-DR alleles with systemic lupus erythematosus in Koreans. J Rheumatol 1994; 21: 442-447.

90.

Fouad F. et al. MHC in systemic lupus erythematosus: a study on a Kuwaiti population . Eur J Immunogenet 1994; 21: 11-14.

91.

Granados J. et al. Further evidence of the role of complement genotypes in the susceptibility to SLE obtained from Mexican family studies . Arthritis Rheum 1987; 30: S21 (abstract).

92.

Kumar A. , Kumar P. , Schur PH DR3 and non-DR3 associated complement component C4A deficiency in systemic lupus erythematosus. Clin Immunol Immunopathol 1991; 60: 55-64.

93.

Benevolenskaia LI et al. The HLA system and its contribution to the genetics of rheumatic diseases. Genetika 1986; 22: 861-867.

94.

Alexeev LP , Petrov RV Unusual association of HLA antigens to systemic lupus erythematosus (SLE) predisposition. Lupus 1995; 4: 42S.

95.

Skarsuag S. et al. Distribution of HLA class II alleles among Scandinavian patients with systemic lupus erythematosus (SLE): an increased risk of SLE among non [DRB 1 *03, DQA 1 *0501, DQB1*0201] class II homozygotes? Tissue Antigens 1992; 40: 128-133.

96.

Howe HS et al. HLA DR antigens in Singapore Malay SLE patients. Lupus 1995; 4: 22S.

97.

Bosak V. et al. Genetic analysis in SLE-Slovak population study. Lupus 1995; 4: 43S.

98.

Klemp P. et al. HLA-A,B,C, and DR antigens, GLO I and Bf marker profiles in 75 Cape coloured patients with systemic lupus erythematosus (SLE). Tissue Antigens 1988; 32: 12-16.

99.

De Juan D. et al. Differential contribution of C4 and HLA-DQ genes to systemic lupus erythematosus susceptibility. Hum Genet 1993; 91: 579-584.

100.

Camps Garcia MT et al. Class I and II HLA antigens in patients with systemic lupus erythematosus in the south of Spain. Med Clin (Barc) 1994; 102: 688-693.

101.

Rantapaa DS , Beckman G. , Beckman L. Serum protein markers in systemic lupus erythematosus . Hum Hered 1988; 38: 44-47.

102.

Sturfelt G. et al. Homozygous C4A deficiency in systemic lupus erythematosus: analysis of patients from a defined population. Clin Genet 1990; 38: 427-433.

103.

Truedsson L. , Sturfelt G. , Nived O. Prevalence of the type I complement C2 deficiency gene in Swedish systemic lupus erythematosus patients. Lupus 1993; 2: 325-327.

104.

Reinharz D. et al. Absence of DRw15/3 and of DRw15/7 heterozygotes in Caucasian patients with systemic lupus erythematosus. Tissue Antigens 1991; 37: 10-15.

105.

Fraser PA et al. Complotypes of individuals of African origin: frequencies and possible extended MHC haplotypes. Immunogenetics 1990; 31: 89-93.

106.

Reveille JD et al. Restriction fragment length polymorphism analysis of HLA-DR, DQ, DP and C4 alleles in Caucasians with systemic lupus erythematosus. J Rheumatol 1991; 18: 14-18.

107.

Reveille JD et al. DNA analysis of HLA-DR and DQ genes in American blacks with systemic lupus erythematosus. Arthritis Rheum 1989; 32: 1243-1251.

108.

Alvarellos A. et al. Relationships of HLA-DR and MT antigens to autoantibody expression in SLE. Arthritis Rheum 1983; 26: 1533-1535.

109.

Hochberg MC et al. Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine 1985; 64: 285-295.

110.

Howard PF et al. Relationship between C4 null genes, HLA-D region antigens and genetic susceptibility to systemic lupus erythematosus in caucasian and black Americans. Am J Med 1986; 81: 187-193.

111.

Petri M. et al. Clinical expression of systemic lupus erythematosus in patients with C4A deficiency. Medicine 1993; 72: 236-244.

112.

Glass D. et al. Inherited deficiency of the second component of complement. Rheumatic disease associations. J Clin Invest 1976; 58: 853-861.

113.

Schur PH et al. The effect of ethnicity on major histocompatibility complex complement allotypes and extended haplotypes in patients with systemic lupus erythematosus. Arthritis Rheum 1990; 33: 985-992.

114.

Kachru RN et al. A significant increase of HLA-DR3 and DR2 in systemic lupus erythematosus among Blacks. J Rheumatol 1984 ; 11: 471-474.

115.

Welch TR et al. Major histocompatibility complex extended haplotypes in systemic lupus erythematosus. Dis Markers 1988; 6: 247-255.

116.

Bishof NA et al. DP polymorphism in HLA-A1, -B8, -DR3 extended haplotypes associated with membranoproliferative glomerulonephritis and systemic lupus erythematosus . Pediatr Nephrol 1993; 7: 243-246.

117.

Arnett FC et al. Connective tissue disease in southeast Georgia. A community based study of immunogenetic markers and autoantibodies. J Rheumatol 1990; 17: 1029-1035.

118.

Wilson WA , Scopelitis E. , Michalski JP Association of HLA-DR7 with both antibody to SSA(Ro) and disease susceptibility in Blacks with systemic lupus erythematosus. J Rheumatol 1984; 11: 653-657.

119.

Kemp ME et al. Deletion of C4A genes in patients with systemic lupus erythematosus . Arthritis Rheum 1987; 30: 1015-1022.

120.

Fronek Z. et al. Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus. Arthritis Rheum 1980; 33: 1542-1553.

121.

Fronek Z. et al. Major histocompatibility complex associations with systemic lupus erythematosus. Am J Med 1988; 85: 42-44.

122.

Olsen ML et al. C4A gene deletion and HLA associations in black Americans with systemic lupus erythematosus. Immunogenetics 1989; 30: 27-33.

123.

Barron KS et al. Clinical serologic, and immunogenetic studies in childhood-onset systemic lupus erythematosus. Arthritis Rheum 1993; 36: 348-354.

124.

Reveille JD et al. HLA-DPB 1 alleles and autoantibody subsets in systemic lupus erythematosus, Sjögren's syndrome and progressive systemic sclerosis: a question of disease relevance. Tissue Antigens 1992 ; 40: 45-48.

125.

Reveille JD et al. HLA-DR, DQ and DP genotypes in Mexican-Americans with systemic lupus erythematosus the importance of autoantibody subsets in HLA/disease associations. Arthritis Rheum 1991 ; 34: S138.

126.

Reveille JD et al. The molecular genetics of systemic lupus erythematosus (SLE) in Mexican-Americans. Arthritis Rheum 1991; 34: S138 (abstract).

127.

Reveille JD , Moulds JM , Arnett FC Major histocompatibility complex class II and C4 alleles in Mexican-Americans with systemic lupus erythematosus. Tissue Antigens 1995; 45: 91-97.

128.

Alarif LI , Ruppert GB , Wilson R.Jr , Barth WF HLA-DR antigens in blacks with rheumatoid arthritis and systemic lupus erythematosus . J Rheumatol 1983; 10: 297-300.

129.

Schur PH et al. Associations between systemic lupus erythematosus and the major histocompatibility complex: clinical and immunological considerations. Clin lmmunol Immunopathol 1982; 24: 263-275.

130.

Griffing WL et al. Associations of antibodies to native DNA with HLA-DRw3. A possible major histocompatibility complex-linked human immune response gene. J Exp Med 1980; 152: 319s-325s.

131.

Khanduja S. , Arnett FC , Reveille JD HLA-DQ beta genes encode an epitope for lupus specific DNA antibodies. Clin Res 1991; 38: 975A (abstract).

132.

Nishikai M. , Sekiguchi S. Relationship of autoantibody expression and HLA phenotype in Japanese patients with connective tissue diseases. Arthritis Rheum 1985; 28: 579-581.

133.

Smnolen JS et al. HLA-DR antigens in systemic lupus erythematosus: association with specificity of autoantibody responses to nuclear antigens . Annal Rheum Dis 1987; 46: 457-462.

134.

Olsen ML , Arnett FC , Reveille JD Contrasting molecular patterns of MHC class II alleles associated with the anti-Sm and anti-RNP precipitin autoantibodies in systemic lupus erythematosus . Arthritis Rheum 1993; 36: 94-104.

135.

Stephens HA et al. HLA class II restriction of autoantibody production in patients with systemic lupus erythematosus. Immunogenetics 1991; 33: 276-280.

136.

Kaneoka H. et al. Molecular genetic analysis of HLA-DR and HLA-DQ genes among anti-U1-70 kd autoantibody positive connective tissue disease patients. Arthritis Rheum 1992; 35: 83-94.

137.

Gomez-Reino JJ et al. Immunogenetics of systemic lupus erythematosus in Spanish patients: differential HLA markers. Immunobiology 1991; 182: 465-471.

138.

Bell DA , Maddison PJ Serologic subsets in systemic lupus erythematosus: an examination of autoantibodies in relationship to clinical features of disease and HLA antigens. Arthritis Rheum 1980; 23: 1268-1272.

139.

Wong KL , Hawkins BR , Wong RW Immunogenetics in Chinese patients with SLE. Scand J Rheumatol 1991; 20: 110-114.

140.

Stephens HA et al. HLA class II restriction of autoantibody production in patients with systemic lupus erythematosus. Immunogenetics 1991; 33: 276-280.

141.

Specker C. et al. Significant association of HLA-B8 with systemic lupus erythematosus and with specific serological markers. Dtsch Med Wochenschr 1987; 112: 577-580.

142.

Hartung K. et al. The genetic basis of Ro and La antibody formation in systemic lupus erythematosus. Results of a multicenter study . Rheumatol Int 1992; 11: 243-249.

143.

Ehrfeld H. et al. MHC associations of autoantibodies against recombinant Ro and La proteins in systemic lupus erythematosus. Rheumatol Int 1992; 12: 169-173.

144.

Provost TT , Arnett FC , Reichlin M. Homozygous C2 deficiency, lupus erythematosus and anti-Ro (SSA) antibodies. Arthritis Rheum 1983; 26: 1279-1282.

145.

Hamilton RG et al. Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus: correlation of HLA-DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibody. Arthritis Rheum 1988; 31: 496-505.

146.

Scofield RH et al. Cooperative association of T cell beta receptor and HLA-DQ alleles in the production of anti-Ro in systemic lupus erythematosus. Clin Immunol Immunopath 1994 ; 72: 335-341.

147.

Scofield RH et al. Immunogenetics of epitopes of the carboxyl terminus of the human 60-kD Ro autoantigen. Clin Exp Immunol 1995; 99: 256-261.

148.

Fujisaku A. et al. HLA-DQ gene complementation and other histocompatibility relationships in man with the anti-Ro/SSA autoantibody response of systemic lupus erythematosus. J Clin Invest 1990; 86: 606-611.

149.

Reveille JD et al. Specific amino acid residues in the second hypervariable region of HLA-DQA 1 and DQB 1 chain genes promote the Ro(SS-A)/La (SS-B) autoantibody responses. J Immunol 1991 ; 146: 3871-3876.

150.

Camps MT et al. Immunogenetics characteristics of lupus patients with secondary antiphospholipid syndrome. Lupus 1995; 4: 22S.

151.

Arnett FC et al. Molecular analysis of major histocompatibility complex alleles associated with the lupus anticoagulant. J Clin Invest 1991 ; 87: 1490-1495.

152.

Reveille JD et al. HLA-DPB alleles and autoantibody subsets in systemic lupus erythematosus, Sjögren's syndrome and progressive systemic sclerosis: a question of disease relevance. Tissue Antigens 1992; 40: 45-48.

153.

McHugh NJ , Maddison PJ HLA-DR antigens and anticardiolipin antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 1989; 32: 1623-1624.

154.

Hartung K. et al. MHC gene products and anticardiolipin antibodies in systemic lupus erythematosus results of a multicenter study . SLE Study Group. Autoitnmunity 1992; 13: 95-99.

155.

Gulko PS et al. Anticardiolipin antibodies in systemic lupus erythematosus: clinical correlates, HLA associations and impact on survival. J Rheumatol 1993; 20: 1684-1693.

156.

Wilson WA et al. Cardiolipin antibodies and null alleles of C4 in black Americans with systemic lupus erythematosus. J Rheumatol 1988; 15: 1768-1772.

157.

Kumana CR et al. Lack of association between slow acetylator status and spontaneous lupus erythematosus. Clin Pharmacol Ther 1990 ; 48: 208-213.

158.

Ong ML et al. The lack of relationship between acetylator phenotype and idiopathic systemic lupus erythematosus in a South-east Asian population: a study of Indians, Malays and Malaysian Chinese. Br J Rheumatol 1990; 29: 462-464.

159.

Reidenberg MM et al. Acetylation phenotypes and environmental chemical exposure of people with idiopathic systemic lupus erythematosus. Arthritis Rheum 1993; 36: 971-973.

160.

Uko G. et al. CR1 deficiency in SLE: acquired or genetic? Clin Exp Immunol 1985; 62: 329-336.

161.

Moldenhauer F. , Botto M. , Walport MJ The rate of loss of CR1 from ageing erythrocytes in vivo in normal subjects and SLE patients: no correlation with structural or numerical polymorphisms. Clin Exp Immunol 1988; 72: 74-78.

162.

Moldenhauer F. et al. Inherited deficiency of erythrocyte complement receptor type 1 does not cause susceptibility to systemic lupus erythematosus. Arthritis Rheum 1987; 30: 961-966.

163.

Holme E. et al. Decreased C3b receptors (CR 1 ) on erythrocytes from patients with systemic lupus erythematosus. Clin Exp Immunol 1986; 63: 41-48.

164.

Walport MJ et al. Family studies of erythrocyte complement receptor type 1 levels: reduced levels in patients with SLE are acquired, not inherited. Clin Exp Immunol 1985; 59: 547-554.

165.

Cornellet P. et al. Increased frequency of the long (S) allotype of CR1 (the C3b/C4b receptor, CD35) in patients with systemic lupus erythematosus. Clin Exp Immunol 1992; 89: 22-25.

166.

Mir A. et al. C3b receptor (CR1) on phagocytic cells from SLE patients: analysis of the defect and familial study. Clin Exp Immunol 1988; 73: 461-466.

167.

Cohen JH et al. Genetic analysis of CR1 expression on erythrocytes of patients with systemic lupus erythematosus. Arthritis Rheum 1989; 32: 393-397.

168.

Satoh H. et al. Distribution of the HindIII restriction fragment length polymorphism among patients with systemic lupus erythematosus with different concentrations of CR1. Ann Rheum Dis 1991; 50: 765-768.

169.

Miyakawa Y. et al. Defective immune-adherence (C3b) receptor on erythrocytes from patients with systemic lupus erythematosus. Lancet 1981; 2: 493-497.

170.

Tebib JG et al. The frequency of complement receptor type 1 (CR1) gene polymorphisms in nine families with multiple cases of systemic lupus erythematosus. Arthritis Rheum 1989; 32: 1465-1469.

171.

Wilson JG et al. Deficiency of the C3b/C4b receptor (CR1) of erythrocytes in systemic lupus erythematosus: analysis of the stability of the defect and of a restriction fragment length polymorphism of the CR 1 gene. J Immunol 1987; 138: 2708-2710.

172.

Iida K. , Mornaghi R. , Nussenzweig V. Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus. J Exp Med 1982; 155: 1427-1438.

173.

Van Dyne S. et al. The polymorphism of the C3b/C4b receptor in the normal population and in patients with systemic lupus erythematosus . Clin Exp Immunol 1987; 68: 570-579.

174.

Whittingham S. , Propert DN , Mackay IR A strong association between the antinuclear antibody anti-La (SS-B) and the kappa chain allotype Km(1). Immunogenetics 1984; 19: 295-299.

175.

Jazwinska EC et al. Gm allogenotype distribution and lack of HLA-DR, Gm interaction in SLE and CREST/PSS. Immunol Cell Biol 1989; 67: 261-265.

176.

Strejcek J. , Herzog P. , Bielicky T. Allotypy of serum immunoglobulins in systemic and chronic lupus erythematosus. Int Arch Allergy 1967; 31: 145-151.

177.

Hartung K. et al. Immunoglobulin allotypes are not associated with HLA-antigens, autoantibodies and clinical symptoms in systemic lupus erythematosus. Members of the SLE Study Group. Rheumatol Int 1991; 11: 179-182.

178.

Hauke G. et al. Immunoglobulin and T cell receptor gene rearrangements in patients with autoimmune diseases. Immun Infekt 1990 ; 18: 96-97.

179.

Hartung K. et al. Immunoglobulin allotypes in systemic lupus erythematosus: results of a central European multicenter study. SLE Study Group. Exp Clin Immunogenet 1991; 8: 11-15.

180.

Schur PH , Pandey JP , Fedrick JA Gm allotypes in white patients with systemic lupus erythematosus. Arthritis Rheum 1985; 28: 828-830.

181.

Fedrick JA et al. Gm allotypes in blacks with systemic lupus erythematosus. Arthritis Rheum 1985; 28: 828-830.

182.

Hoffman RW et al. Association of immunoglobulin Km and Gm allotypes with specific antinuclear antibodies and disease susceptibility among connective tissue disease patients. Arthritis Rheum 1991; 34: 453-458.

183.

Singh R. , Mullinax PF , Moxley G. Systemic lupus erythematosus is not associated with allotypic markers of immunoglobulin kappa in Caucasians. J Rheumatol 1994; 21: 839-842.

184.

Dunckley H. , Gatenby PA , Serjeantson SW T cell receptor and HLA class II RFLPs in systemic lupus erythematosus. Immunogenetics 1988; 27: 392-395.

185.

Ikaheimo IL et al. Different distribution of T cell receptor beta-chain haplotypes in mixed connective tissue disease and systemic lupus erythematosus. Ann Med 1994; 26: 129-132.

186.

Morito F. et al. Genetic analysis of systemic lupus erythematosus: association with a T cell receptor restriction fragment length polymorphism in Japanese patients. Intern Med 1992; 31: 998-1003.

187.

Tebib JG et al. Association between a T cell receptor restriction fragment length polymorphism and systemic lupus erythematosus. J Clin Invest 1990; 86: 1961-1967.

188.

Wong DW et al. Non-linkage of the T cell receptor alpha, beta and gamma genes to systemic lupus erythematosus in multiplex families. Arthritis Rheum 1988; 31: 1371-1376.

189.

Fronek Z. et al. Systemic lupus erythematosus is not genetically linked to the beta chain of the T cell receptor. Arthritis Rheum 1986; 29: 1023-1025.

190.

Graninger WB Transcriptional overexpression of the proto-oncogene bcl-2 in patients with systemic lupus erythematosus. Wien Klin Wochenschr 1992; 104: 205-207.

191.

Jiang Z. , Du C. Studies of the relationship between transferrin genetic polymorphism and diseases . I Chuan Hseuh Pao 1992; 19: 298-202.

192.

Chan SH et al. HLA and systemic lupus erythematosus in Chinese. Hum Immunol 1981; 3: 345-350.

193.

Fugger L. et al. IL-6 gene polymorphism in rheumatoid arthritis, pauciarticular juvenile rheumatoid arthritis, systemic lupus erythematosus, and in healthy Danes. J Immunogenet 1989; 16: 461-465.

194.

Davies EJ et al. Mannose-binding protein gene polymorphism in systemic lupus erythematosus. Arthritis Rheum 1995; 38: 110-114.

195.

Blakemore AI et al. Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus . Arthritis Rheum 1994; 37: 1380-1385.

196.

Wysenbeek AJ et al. Expression of systemic lupus erythematosus in various ethnic Jewish Israeli groups. Ann Rheum Dis 1993; 52: 268-271.

197.

Atsumi T. Tumor necrosis factor alpha in systemic lupus erythematosus: evaluation by restriction fragment length polymorphism and production by peripheral blood mononuclear cells. Hokkaido Igaku Zasshi 1992 ; 67: 408-419.

198.

Kawai T. et al. HLA antigens in Japanese patients with central nervous system lupus. Tissue Antigens 1990; 35: 45-46.

199.

Teh LS , Doherty DG , Williams BD HLA-DRB genes and antiribosomal P antibodies in systemic lupus erythematosus . Br J Rheumatol 1994; 33: 1125-1126.

200.

Kumar A. et al. Immunoglobulin heavy chain constant-region gene polymorphism in systemic lupus erythematosus. Arthritis Rheum 1991 ; 34: 1553-1556.

201.

Glavinskaia TA et al. HLA and ceruloplasmin phenotypes in lupus erythematosus and circumscribed scleroderma. Vestn Dermatol Venerol 1989; 6: 9-13.

202.

Welch TR , Berry A. C3 alleles in diseases associated with C3 activation. Dis Markers 1987; 5: 81-87.

203.

Jazwinska EC et al. Fc gamma RII restriction fragment length polymorphism (RFLP): analysis in systemic lupus erythematosus and scleroderma and evidence of an alpha gene duplication. Clin Exp Immuuol 1991; 83: 47-51.

204.

Harley JB et al. Systemic lupus erythematosus: considerations for a genetic approach . J Invest Dermatol 1994; 103: 144S-149S.

205.

Freedman BI et al. A race-controlled human leukocyte antigen frequency analysis in lupus nephritis. Am J Kidney Dis 1993; 21: 378-382.

206.

Watson RM et al. Subacute cutaneous lupus erythematosus-immunogenetic associations . J Autoimmun 1991; 4: 73-85.

207.

Schur PH Fingerprint analysis of patients with systemic lupus erythematosus and their relatives. J Rheumatol 1990; 17: 482-484.

208.

Jacob CO et al. Heritable major histocompatibility complex class IIassociated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 1990; 87: 1233-1237.

209.

Dubois RW , Weiner JM , Dubois EL Dermatoglyphic study of systemic lupus erythematosus. Arthritis Rheum 1976; 19: 87-97.

210.

Gammon WR , Briggman RA Bullous Sle. A phenotypically distinctive but immunologically heterogeneous bullous disorder . J Invest Dermatol 1993; 100: 28S-34S.

211.

Frank MB et al. Anti-Ro(SSA) autoantibodies are associated with T cell receptor beta genes in systemic lupus erythematosus patients. J Clin Invest 1990; 85: 33-39.

212.

Shoenfeld Y. et al. Diversity and pattern of inheritance of autoantibodies in families with multiple cases of systemic lupus erythematosus . Ann Rheum Dis 1992; 51: 611-618.

213.

Teh LS et al. Antiribosomal P protein antibodies in different populations of patients with systemic lupus erythematosus. Br J Rheumatol 1993; 32: 663-665.

214.

Citera G. , Wilson WA Ethnic and geographic perspectives in SLE. Lupus 1993; 2: 351-353.

215.

Schur PH , Carpenter CB Sharing of HLA haplotype by parents of patients with systemic lupus erythematosus . Arthritis Rheum 1983; 26: 1104-1110.

216.

Hartung K. et al. Hetero- and homozygosity of MHC class II gene products in systemic lupus erythematosus. The Members of the Deutsche Multizentrische SLE- Studie. Tissue Antigens 1991; 38: 165-168.

217.

Schur PH Inherited complement component abnormalities. Ann Rev Med 1986; 37: 333-346.

218.

Walport MJ Complement deficiency in SLE. Lupus 1995; 4: 8 (abstract).

219.

Kono DH et al. Lupus susceptibility loci in New Zealand mice. Proc Natl Acad Sci USA 1994; 91: 10168-10172.

220.

Tan EM et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1272-1277.

221.

Hart HH , Grigor RR , Caughey DE Ethnic difference in the prevalence of systemic lupus erythematosus. Ann Rheum Dis 1983; 42: 529-532.

222.

Johnson AE et al. Cross-sectional analysis of the differences between patients with systemic lupus erythematosus in England, Brazil and Sweden. Lupus 1994; 3: 501-506.

223.

A Meyer O. A critical appraisal of the classification criteria for systemic lupus erythematosus . Clin Exp R heum 1994; 12 (suppl.): S41-S44.

224.

Lander ES Schork NJ Genetic dissection of complex traits. Science 1994; 265: 2037-2048.

225.

James JA et al. Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B'-derived PPPGMRPP and PPPGIRGP induce spiceosome autoimmunity. J Exp Med 1995; 181: 453-461.

226.

Elson CJ et al. Immunologically ignorant autoreactive T cells, epitope spreading and repertoire limitation. Immunol Today 1995 ; 16: 71-76.

227.

Shoenfeld Y. Idiotypic induction of autoimmunity: a new aspect of the idiotypic network. FASEB J 1994 ; 8: 1296-1301.

228.

Reichlin M. Autoantibodies to the RoRNP particles. Clin Exp Immunol 1995; 99: 7-9.

229.

Russell GI et al. Hydralazine sensitivity: clinical features, autoantibody changes and HLA-DR phenotype. Q J Med 1987; 65: 845-852.

230.

Mountz JD et al. Autoimmune disease. A problem of defective apoptosis. Arth Rheum 1994; 37: 1415-1420.

231.

Theofiliopoulos AH The basis of autoimmunity. 1. Mechanisms of aberrant self-recognition. Immunol Today 1995 ; 16: 90-98.

232.

Theofilopoulos AN The basis of autoimmunity. 2. Genetic predisposition . Immunol Today 1995; 18: 150-158.

233.

Kammer GM , Khan IU , Malemud CJ Deficient type I protein kinase A isozyme activity in systemic lupus erythematosus T lymphocytes. J Clin Invest 1994; 94: 422-430.

234.

Wicks I. , McColl G. , Harrison L. New perspectives on rheumatoid arthritis. Immunol Today 1994; 15: 553-556.

235.

Bach JF Predictive medicine in autoimmune diseases: from the identification of genetic predisposition and environmental influence to precocious immunotherapy. Clin Immunol Immunopath 1994; 72: 156-161.

236.

Alper CA et al. Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med 1989; 321: 708-712.

237.

Thursz MR et al. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med 1995; 332: 1065-1069.

238.

Lepage V. et al. HLA-Cw7 and HBsAg negative chronic active hepatitis. Tissue Antigens 1991; 18: 105-107.

239.

Apple RJ et al. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nat Genet 1994; 6: 157-162.

240.

Ayoub EM et al. Association of class II human histocompatibility leukocyte antigens with rheumatic fever. J Clin Invest 1986; 77: 2019-2026.

241.

Kalish RA , Leong JM , Steere AC Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect Immun 1993; 61: 2774-2779.

242.

Potts WK , Wakeland EK Evolution of MHC genetic diversity: a tale of incest, pestilence and sexual preference. Trends Genet 1993; 9: 408-412.

243.

Weyand CM et al. The influence of HLA-DRB 1 genes on disease severity in rheumatoid arthritis. Ann Intern Med 1992; 117: 801-806.

244.

Behar SM , Porcelli SA Mechanisms of autoimmune disease induction. The role of the immune response to microbial pathogens. Arthritis Rheum 1995 ; 38: 458-476.

245.

Penny MA et al. An investigation of the association between HLA-DQ heterodimers and type 1 (insulin-dependent) diabetes mellitus in five racial groups. Hum Immunol 1993; 38: 179-183.